Why Disease Intelligence Comes Before Target Selection
A field note on disease states, patient-relevant biology, and why target discovery needs a richer operating model.
May 2026 / 7 min read
Insights
Research notes, essays, technical perspectives, and field analysis from the frontier of disease intelligence.
A field note on disease states, patient-relevant biology, and why target discovery needs a richer operating model.
May 2026 / 7 min read
A compact template for linking subtype, perturbation, expected outcome, and confidence.
May 2026 / 4 min read
How intervention type changes when the biological action is activation, inhibition, degradation, or modulation.
May 2026 / 6 min read
Faster generation does not solve uncertainty. Better maps do.
May 2026 / 5 min read
Why recommendations need provenance, contradiction handling, confidence scoring, and explicit gaps.
May 2026 / 8 min read
The path from hypothesis to biomarker strategy, assay design, model selection, and translational readout.
May 2026 / 6 min read
A short perspective on disease heterogeneity, mechanism-level subtyping, and intervention timing.
May 2026 / 9 min read
How subtype-aware maps can make competing intervention paths easier to compare.
May 2026 / 6 min read
A short note on mechanism confidence, evidence maturity, translation risk, and uncertainty windows.
May 2026 / 5 min read
Why the best AI biology systems should be judged by how they improve the next experiment.
May 2026 / 7 min read
Biomarkers, endpoints, model systems, and readouts that make hypotheses decision-ready.
May 2026 / 8 min read
Why the same target can imply different therapeutic forms depending on the required biological action.
May 2026 / 4 min read
Article Viewer
The insights hub is structured for dedicated article pages with title, subtitle, author, date, tags, hero image, article body, related articles, and a closing path back into the technology platform.